Clinical Trials Browser

Phase EARLY_PHASE1 × INDUSTRY × Hematologic Neoplasms × Clear all

NCT07131254 2025-12-30

A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in Adult Participants With Relapsed/Refractory CD19-positive B-cell Malignant Hematological Tumors

Phase EARLY_PHASE1 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms

NCT03537482 2024-08-19

APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies

Phase EARLY_PHASE1 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms

NCT05707325 2024-07-24

Reboot-101

Phase EARLY_PHASE1 Recruiting

Other hematologic neoplasm

Neoplasms, Hematologic Neoplasms

NCT04700319 2021-03-08

CAR-T CD19/CD20 for Patients With Advanced CD19/CD20+ B Cell Line Recurrent or Refractory Hematological Malignancies

Phase EARLY_PHASE1 Unknown

Other hematologic neoplasm

Hematologic Neoplasms